NASDAQ:PGEN
Precigen, Inc. Stock News
$1.39
+0 (+0%)
At Close: May 21, 2024
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
07:43pm, Monday, 01'st Mar 2021
Precigen, Inc. (PGEN) delivered earnings and revenue surprises of 31.25% and -16.13%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Precigen, Inc. (PGEN) Report Negative Q4 Earnings? What You Should Know
01:42pm, Monday, 22'nd Feb 2021
Precigen, Inc. (PGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Troll-able Stocks That Could Be the Next GME
10:55am, Wednesday, 17'th Feb 2021
The next GME will be hard to find, but these three stocks could be solid candidates for a potential short squeeze. The post 3 Troll-able Stocks That Could Be the Next GME appeared first on InvestorPla
10 Short Squeeze Candidates Under $10
08:36am, Saturday, 30'th Jan 2021
The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's
Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
04:05pm, Tuesday, 26'th Jan 2021
GERMANTOWN, Md., Jan. 26, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) announced today the closing of its previously announced underwritten public offering of common stock. Precigen sold 17,250,
Precigen Announces Pricing of $112.5 Million Public Offering of Common Stock
08:05am, Friday, 22'nd Jan 2021
GERMANTOWN, Md., Jan. 22, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public offerin
Precigen Announces Proposed Public Offering of Common Stock
04:01pm, Thursday, 21'st Jan 2021
GERMANTOWN, Md., Jan. 21, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) today announced it has commenced an underwritten public offering of shares of its common stock. In addition, Precigen inten
Precigen to Present at the 39th Annual J.P. Morgan Healthcare Conference
08:05am, Wednesday, 06'th Jan 2021
GERMANTOWN, Md., Jan. 6, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of p
GERMANTOWN, Md., Jan. 5, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of p
Precigen Provides Latest Clinical Developments at Virtual R&D Update Event
07:37pm, Tuesday, 15'th Dec 2020
GERMANTOWN, Md., Dec. 15, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of
GERMANTOWN, Md., Dec. 7, 2020 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Precigen, Inc. f/k/a Intrexon Corporation (�
San Francisco, California--(Newsfile Corp. - December 4, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A sec
PGEN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourage Investors with Losses in Excess of $100K to Contact Firm - PGEN, XON
05:29pm, Thursday, 03'rd Dec 2020
New York, New York--(Newsfile Corp. - December 3, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Precigen, Inc. f/k/a Intrexon Corporation (NASDAQ:
Los Angeles, California--(Newsfile Corp. - December 3, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Precigen, In
